C
1.81
0.02 (1.12%)
Penutupan Terdahulu | 1.79 |
Buka | 1.80 |
Jumlah Dagangan | 998,696 |
Purata Dagangan (3B) | 1,555,261 |
Modal Pasaran | 692,381,120 |
Harga / Pendapatan (P/E TTM) | 16.45 |
Harga / Jualan (P/S) | 5.85 |
Harga / Buku (P/B) | 0.650 |
Julat 52 Minggu | |
Tarikh Pendapatan | 7 May 2025 - 12 May 2025 |
Margin Keuntungan | 34.93% |
Margin Operasi (TTM) | -45.30% |
EPS Cair (TTM) | 0.110 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 26.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 0.18% |
Nisbah Semasa (MRQ) | 18.83 |
Aliran Tunai Operasi (OCF TTM) | 18.84 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -26.29 M |
Pulangan Atas Aset (ROA TTM) | -2.94% |
Pulangan Atas Ekuiti (ROE TTM) | 3.63% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
Stok | Cronos Group Inc. Common Share | Bercampur | Menaik |
AISkor Stockmoo
-0.2
Konsensus Penganalisis | -2.0 |
Aktiviti Orang Dalam | -1.5 |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | 2.0 |
Purata | -0.20 |
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 46.22% |
% Dimiliki oleh Institusi | 14.06% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Chescapmanager Llc | 31 Dec 2024 | 7,950,237 |
Timelo Investment Management Inc. | 31 Dec 2024 | 641,803 |
Tiada data dalam julat masa ini.
Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
---|---|---|---|---|
DOUCET TERRENCE GREGORY JOSEPH | - | 2.05 | -6,266 | -12,845 |
WAGNER ADAM | - | - | 0 | 0 |
WEIGENSBERG ARYE | - | - | 0 | 0 |
Jumlah Keseluruhan Kuantiti Bersih | -6,266 | |||
Jumlah Keseluruhan Nilai Bersih ($) | -12,845 | |||
Purata Pembelian Keseluruhan ($) | - | |||
Purata Jualan Keseluruhan ($) | 2.05 |
Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
---|---|---|---|---|---|---|
WAGNER ADAM | Pegawai | 12 May 2025 | Pelaksanaan pilihan | 6,276 | - | - |
WEIGENSBERG ARYE | Pegawai | 12 May 2025 | Pelaksanaan pilihan | 9,014 | - | - |
DOUCET TERRENCE GREGORY JOSEPH | Pegawai | 12 May 2025 | Dibuang (-) | 6,266 | 2.05 | 12,845 |
DOUCET TERRENCE GREGORY JOSEPH | Pegawai | 12 May 2025 | Pelaksanaan pilihan | 12,876 | - | - |
Tarikh | Jenis | Butiran |
---|---|---|
08 May 2025 | Pengumuman | Cronos Group Reports 2025 First Quarter Results |
28 Apr 2025 | Pengumuman | Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders |
24 Apr 2025 | Pengumuman | Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025 |
22 Apr 2025 | Pengumuman | Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids |
19 Mar 2025 | Pengumuman | Cronos Appoints Anna Shlimak as Chief Financial Officer |
27 Feb 2025 | Pengumuman | Cronos Group Reports 2024 Fourth Quarter and Full-Year Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |